Brightstone Venture Capital
VC Fund
Minneapolis, United States
Brightstone Venture Capital is a VC fund in Minneapolis focused on Health Care and Software. Brightstone Venture Capital (BVC) has a 30 year history of building successful technology and life-science companies. We love to partner with extraordinary entrepreneurs with a unique vision of how to solve a huge problem in a large and growing market, and help them "dream big" and achieve their vision.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 10%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Brightstone Venture Capital invests in
Stages Brightstone Venture Capital invests in
Countries Brightstone Venture Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.2M–$2.5M
- Series A
- $3.5M–$16M
- Series B
- $13M–$44M
Investment Focus
Industry
- Health Care 9 (23%)
- Software 7 (18%)
- Medical 4 (10%)
- Therapeutics 4 (10%)
- Biotechnology 4 (10%)
Stage
- Seed 14 (36%)
- Series A 9 (23%)
- Series B 5 (13%)
- Series C 2 (5%)
- Funding Round 2 (5%)
Country
- United States 28 (72%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Dalvey
Managing General Partner
|
Managing General Partner | Total investments: 0 | Find email | |
David Dalvey
Managing General Partner
|
Managing General Partner | Total investments: 0 | Find email | |
Jeffrey Cowan
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
Patrick O'Shaughnessy
Managing Partner
|
Managing Partner | Total investments: 17 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xplore
|
Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions. | $16.2M / Series A / Feb 24, 2022 | |
|
Xplore
|
Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions. | $16.2M / Series A / Feb 24, 2022 | |
|
Xplore
|
Xplore is flying commercial missions in Earth orbits with their XCRAFT™, and they invite you to join us. They take civilian, commercial and national security payloads to their desired orbit around Earth for their science or reconnaissance missions. | $7.2M / Venture - Series Unknown / Feb 24, 2022 | |
Mosaic
|
Mosaic is a construction technology company building software to make residential construction more scalable. The company operates as a digital general contractor to provide construction and related services to homebuilders and residential developers, allowing them to offload their construction processes and related needs to Mosaic’s integratedplatform and team. Mosaic’s platform standardizes the construction process, and not the homes, allowing them to deliver places people love and create better communities. | $44M / Series B / Nov 01, 2021 | |
Afriex
|
Afriex is a pioneering platform that allows its users to send and receive money to anybody around the globe. We use stablecoins to offer the fastest and cheapest remittance service to over 30 countries around the world. | $1.2M / Seed / Mar 22, 2021 | |
Eternal
|
Eternal develops an avatar social network to offer a new social networking experience. Launching a private beta in January 2020. Founded in 2018, Eternal is based in Brooklyn, New York. | Seed / Oct 01, 2020 | |
Cryosa
|
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea. | $8.3M / Series A / Jun 25, 2020 | |
|
Cryosa
|
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea. | Series A / May 05, 2020 | |
Aria CV
|
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart. | $31M / Series B / Feb 25, 2020 | |
|
Aria CV
|
Aria CV was founded in 2010 by Drs. John Scandurra and Karl Vollmers, formerly Fellows at the University of Minnesota’s Medical Devices Center. Aria has an exclusive license to certain patents from the University of Minnesota. Aria CV’s device has the potential to improve outcomes by reducing the workload on the right side of the heart. | Series B / Jan 31, 2020 | |
| See all 39 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Brightstone Venture Capital invest in?
Brightstone Venture Capital invests primarily in Health Care, Software and Medical startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Brightstone Venture Capital's check size?
Brightstone Venture Capital typically joins rounds of $1.2M–$2.5M at Seed, $3.5M–$16M at Series A and $13M–$44M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Brightstone Venture Capital participates in.
How do I contact Brightstone Venture Capital?
Public channels for Brightstone Venture Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Brightstone Venture Capital?
The team at Brightstone Venture Capital includes David Dalvey (Managing General Partner), David Dalvey (Managing General Partner) and Jeffrey Cowan (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
